ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	REACTOME_PATHWAY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
ENSG00000198682	3'-phosphoadenosine 5'-phosphosulfate synthase 2(PAPSS2)	Homo sapiens				GO:0000103~sulfate assimilation,GO:0001501~skeletal system development,GO:0007596~blood coagulation,GO:0016310~phosphorylation,GO:0050428~3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,GO:0060348~bone development,	GO:0005829~cytosol,	GO:0004020~adenylylsulfate kinase activity,GO:0004781~sulfate adenylyltransferase (ATP) activity,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,	IPR002650:Sulphate adenylyltransferase,IPR002891:Adenylylsulphate kinase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR015947:PUA-like domain,IPR024951:Sulphate adenylyltransferase catalytic domain,IPR025980:ATP-sulfurylase PUA-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa00450:Selenocompound metabolism,hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	612847~Brachyolmia 4 with mild epiphyseal and metaphyseal changes,		R-HSA-174362:R-HSA-174362,R-HSA-2408550:R-HSA-2408550,R-HSA-3560796:R-HSA-3560796,		3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Dwarfism,Kinase,Multifunctional enzyme,Nucleotide-binding,Nucleotidyltransferase,Polymorphism,Reference proteome,Transferase,	active site:Phosphoserine intermediate,chain:Bifunctional 3'-phosphoadenosine 5'- phosphosulfate synthase 2,helix,nucleotide phosphate-binding region:ATP,region of interest:Adenylyl-sulfate kinase,region of interest:Sulfate adenylyltransferase,sequence conflict,sequence variant,short sequence motif:PP-motif,splice variant,strand,turn,
ENSG00000111696	5'-nucleotidase domain containing 3(NT5DC3)	Homo sapiens				GO:0016311~dephosphorylation,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043235~receptor complex,	GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,			PIRSF017434:cytosolic purine 5'-nucleotidase,			Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,chain:5'-nucleotidase domain-containing protein 3,compositionally biased region:Poly-Ala,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,region of interest:Substrate binding,sequence variant,splice variant,
ENSG00000185013	5'-nucleotidase, cytosolic IB(NT5C1B)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism / General function prediction only,	GO:0006195~purine nucleotide catabolic process,GO:0009117~nucleotide metabolic process,GO:0016311~dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0008253~5'-nucleotidase activity,	IPR010394:5-nucleotidase,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,			R-HSA-74259:R-HSA-74259,		Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Nucleotide metabolism,Reference proteome,	active site:Nucleophile,active site:Proton acceptor,binding site:Substrate,chain:Cytosolic 5'-nucleotidase 1B,chain:Retinol dehydrogenase 14,compositionally biased region:Poly-Gln,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,nucleotide phosphate-binding region:NADP,sequence conflict,splice variant,
ENSG00000123836	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2(PFKFB2)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0006089~lactate metabolic process,GO:0006096~glycolytic process,GO:0009749~response to glucose,GO:0016311~dephosphorylation,GO:0032024~positive regulation of insulin secretion,GO:0033133~positive regulation of glucokinase activity,GO:0046835~carbohydrate phosphorylation,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04152:AMPK signaling pathway,hsa04919:Thyroid hormone signaling pathway,			R-HSA-70171:R-HSA-70171,	SM00855:SM00855,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 2,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence conflict,splice variant,
ENSG00000008277	ADAM metallopeptidase domain 22(ADAM22)	Homo sapiens				GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,GO:0008344~adult locomotory behavior,GO:0022011~myelination in peripheral nervous system,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				R-HSA-5682910:R-HSA-5682910,	SM00050:DISIN,SM00608:ACR,	3D-structure,Alternative splicing,Cell adhesion,Cell projection,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 22,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000143382	ADAMTS like 4(ADAMTSL4)	Homo sapiens				GO:0002064~epithelial cell development,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0030198~extracellular matrix organization,GO:0036066~protein O-linked fucosylation,GO:0043065~positive regulation of apoptotic process,	GO:0005614~interstitial matrix,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0002020~protease binding,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR000884:Thrombospondin, type 1 repeat,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,		225100~Ectopia lentis, isolated, autosomal recessive,225200~Ectopia lentis et pupillae,		R-HSA-5173214:R-HSA-5173214,	SM00209:TSP1,	Alternative splicing,Apoptosis,Complete proteome,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:ADAMTS-like protein 4,compositionally biased region:Pro-rich,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
ENSG00000184675	APC membrane recruitment protein 1(AMER1)	Homo sapiens				GO:0016055~Wnt signaling pathway,GO:0031398~positive regulation of protein ubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048856~anatomical structure development,GO:0060348~bone development,GO:0060612~adipose tissue development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0072161~mesenchymal cell differentiation involved in kidney development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903364~positive regulation of cellular protein catabolic process,GO:1904885~beta-catenin destruction complex assembly,GO:1904886~beta-catenin destruction complex disassembly,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008013~beta-catenin binding,GO:1904713~beta-catenin destruction complex binding,	IPR019003:Uncharacterised protein family FAM123,		300373~Osteopathia striata with cranial sclerosis,		R-HSA-195253:R-HSA-195253,R-HSA-196299:R-HSA-196299,R-HSA-4641262:R-HSA-4641262,R-HSA-5339716:R-HSA-5339716,R-HSA-5358747:R-HSA-5358747,R-HSA-5358749:R-HSA-5358749,R-HSA-5358751:R-HSA-5358751,R-HSA-5358752:R-HSA-5358752,R-HSA-5467337:R-HSA-5467337,R-HSA-5467340:R-HSA-5467340,R-HSA-5467348:R-HSA-5467348,		3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Lipid-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Wnt signaling pathway,	chain:Protein FAM123B,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,sequence variant,splice variant,
ENSG00000154263	ATP binding cassette subfamily A member 10(ABCA10)	Homo sapiens			Defense mechanisms,	GO:0006869~lipid transport,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			R-HSA-1369062:R-HSA-1369062,	SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 10,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000023839	ATP binding cassette subfamily C member 2(ABCC2)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0006979~response to oxidative stress,GO:0009408~response to heat,GO:0015723~bilirubin transport,GO:0015732~prostaglandin transport,GO:0030644~cellular chloride ion homeostasis,GO:0031427~response to methotrexate,GO:0043627~response to estrogen,GO:0046685~response to arsenic-containing substance,GO:0048545~response to steroid hormone,GO:0055085~transmembrane transport,GO:0070327~thyroid hormone transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0046581~intercellular canaliculus,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008514~organic anion transmembrane transporter activity,GO:0015127~bilirubin transmembrane transporter activity,GO:0019904~protein domain specific binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005292:Multi drug resistance-associated protein,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,	237500~Dubin-Johnson syndrome,		R-HSA-382556:R-HSA-382556,R-HSA-5679001:R-HSA-5679001,	SM00382:AAA,	ATP-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Canalicular multispecific organic anion transporter 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000133657	ATPase 13A3(ATP13A3)	Homo sapiens				GO:0006812~cation transport,GO:0006874~cellular calcium ion homeostasis,GO:0098655~cation transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019829~cation-transporting ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006544:Cation-transporting P-type ATPase, subfamily  V,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,						Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:4-aspartylphosphate intermediate,chain:Probable cation-transporting ATPase 13A3,compositionally biased region:Poly-Tyr,metal ion-binding site:Magnesium,modified residue,sequence conflict,splice variant,transmembrane region,
ENSG00000178409	BEN domain containing 3(BEND3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0034773~histone H4-K20 trimethylation,GO:0036124~histone H3-K9 trimethylation,GO:0043967~histone H4 acetylation,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,	GO:0000182~rDNA binding,GO:0005515~protein binding,	IPR018379:BEN domain,					SM01025:SM01025,	Chromatin regulator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BEN domain-containing protein 3,domain:BEN 1,domain:BEN 2,domain:BEN 3,domain:BEN 4,modified residue,sequence conflict,
ENSG00000222009	BTB domain containing 19(BTBD19)	Homo sapiens							IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,					SM00225:BTB,SM00875:SM00875,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,
ENSG00000117281	CD160 molecule(CD160)	Homo sapiens				GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0050776~regulation of immune response,GO:0050829~defense response to Gram-negative bacterium,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032393~MHC class I receptor activity,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				R-HSA-198933:R-HSA-198933,		Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,	chain:CD160 antigen,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,
ENSG00000138346	DNA replication helicase/nuclease 2(DNA2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000076~DNA replication checkpoint,GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006264~mitochondrial DNA replication,GO:0006284~base-excision repair,GO:0032508~DNA duplex unwinding,GO:0033567~DNA replication, Okazaki fragment processing,GO:0043137~DNA replication, removal of RNA primer,GO:0043504~mitochondrial DNA repair,GO:0045740~positive regulation of DNA replication,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902990~mitotic telomere maintenance via semi-conservative replication,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005760~gamma DNA polymerase complex,GO:0042645~mitochondrial nucleoid,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0016890~site-specific endodeoxyribonuclease activity, specific for altered base,GO:0017108~5'-flap endonuclease activity,GO:0043139~5'-3' DNA helicase activity,GO:0043142~single-stranded DNA-dependent ATPase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR014808:DNA replication factor Dna2, N-terminal,IPR026851:Dna2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03030:DNA replication,	615156~Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6,615807~Seckel syndrome 8,		R-HSA-174437:R-HSA-174437,R-HSA-5685938:R-HSA-5685938,R-HSA-5685942:R-HSA-5685942,R-HSA-5693554:R-HSA-5693554,R-HSA-5693568:R-HSA-5693568,R-HSA-5693579:R-HSA-5693579,R-HSA-5693607:R-HSA-5693607,R-HSA-5693616:R-HSA-5693616,R-HSA-69166:R-HSA-69166,R-HSA-69473:R-HSA-69473,		3D-structure,4Fe-4S,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA replication,DNA-binding,Dwarfism,Endonuclease,Helicase,Hydrolase,Iron,Iron-sulfur,Mental retardation,Metal-binding,Mitochondrion,Multifunctional enzyme,Nuclease,Nucleotide-binding,Nucleus,Progressive external ophthalmoplegia,Proteomics identification,Reference proteome,	chain:DNA2-like helicase,nucleotide phosphate-binding region:ATP,splice variant,
ENSG00000147912	F-box protein 10(FBXO10)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006915~apoptotic process,GO:0016567~protein ubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0042981~regulation of apoptotic process,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR006626:Parallel beta-helix repeat,IPR006633:Carbohydrate-binding/sugar hydrolysis domain,IPR007742:Periplasmic copper-binding protein NosD, beta helix domain,IPR011050:Pectin lyase fold/virulence factor,IPR012334:Pectin lyase fold,IPR022441:Parallel beta-helix repeat-2,				R-HSA-983168:R-HSA-983168,	SM00256:FBOX,SM00710:PbH1,SM00722:CASH,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box only protein 10,domain:F-box,repeat:PbH1 1,repeat:PbH1 10,repeat:PbH1 11,repeat:PbH1 12,repeat:PbH1 13,repeat:PbH1 14,repeat:PbH1 15,repeat:PbH1 16,repeat:PbH1 17,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,repeat:PbH1 5,repeat:PbH1 6,repeat:PbH1 7,repeat:PbH1 8,repeat:PbH1 9,sequence conflict,sequence variant,
ENSG00000181773	G protein-coupled receptor 3(GPR3)	Homo sapiens				GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0040020~regulation of meiotic nuclear division,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000723:G protein-coupled receptor 3/6/12 orphan,IPR000984:G protein-coupled receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,						Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000119737	G protein-coupled receptor 75(GPR75)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070098~chemokine-mediated signaling pathway,GO:1901214~regulation of neuron death,	GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,						Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 75,compositionally biased region:Phe-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000188092	G protein-coupled receptor 89B(GPR89B)	Homo sapiens				GO:0006811~ion transport,GO:0015031~protein transport,GO:0034765~regulation of ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051452~intracellular pH reduction,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0032580~Golgi cisterna membrane,	GO:0004871~signal transducer activity,GO:0005244~voltage-gated ion channel activity,GO:0008308~voltage-gated anion channel activity,	IPR015672:GPCR 89-related,IPR022535:Golgi pH regulator, conserved domain,IPR025969:Abscisic acid G-protein coupled receptor-like domain,						Alternative splicing,Complete proteome,Glycoprotein,Golgi apparatus,Ion channel,Ion transport,Membrane,Protein transport,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Protein GPR89,chain:Putative protein GPR89C,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,transmembrane region,
ENSG00000100890	KIAA0391(KIAA0391)	Homo sapiens				GO:0001682~tRNA 5'-leader removal,GO:0008033~tRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:0090646~mitochondrial tRNA processing,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,	GO:0004526~ribonuclease P activity,					R-HSA-6785470:R-HSA-6785470,		3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,tRNA processing,	chain:Mitochondrial ribonuclease P protein 3,modified residue,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
ENSG00000157193	LDL receptor related protein 8(LRP8)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,h_reelinPathway:Reelin Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001523~retinoid metabolic process,GO:0006508~proteolysis,GO:0006629~lipid metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0021541~ammon gyrus development,GO:0021987~cerebral cortex development,GO:0032793~positive regulation of CREB transcription factor activity,GO:0038026~reelin-mediated signaling pathway,GO:0042493~response to drug,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050804~modulation of synaptic transmission,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0071363~cellular response to growth factor stimulus,GO:0071397~cellular response to cholesterol,GO:1900006~positive regulation of dendrite development,	GO:0005576~extracellular region,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008035~high-density lipoprotein particle binding,GO:0019894~kinesin binding,GO:0030229~very-low-density lipoprotein particle receptor activity,GO:0034185~apolipoprotein binding,GO:0038025~reelin receptor activity,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,		608446~Myocardial infarction, susceptibility to,		R-HSA-432142:R-HSA-432142,R-HSA-975634:R-HSA-975634,	SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Low-density lipoprotein receptor-related protein 8,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,glycosylation site:N-linked (GlcNAc...),region of interest:Clustered O-linked oligosaccharides,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000121454	LIM homeobox 4(LHX4)	Homo sapiens				GO:0001890~placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008045~motor neuron axon guidance,GO:0009887~organ morphogenesis,GO:0021526~medial motor column neuron differentiation,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		262700~Pituitary hormone deficiency, combined, 4,			SM00132:LIM,SM00389:HOX,	Chromosomal rearrangement,Complete proteome,Disease mutation,DNA-binding,Dwarfism,Homeobox,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx4,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence conflict,sequence variant,
ENSG00000180834	MAP6 domain containing 1(MAP6D1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0018009~N-terminal peptidyl-L-cysteine N-palmitoylation,	GO:0005798~Golgi-associated vesicle,GO:0005801~cis-Golgi network,GO:0005874~microtubule,	GO:0005516~calmodulin binding,GO:0008017~microtubule binding,	IPR007882:STOP/MAP6,						Calmodulin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Lipoprotein,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,	chain:MAP6 domain-containing protein 1,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,
ENSG00000061676	NCK associated protein 1(NCKAP1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,		GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0010592~positive regulation of lamellipodium assembly,GO:0016032~viral process,GO:0016601~Rac protein signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0031209~SCAR complex,GO:0031258~lamellipodium membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0048365~Rac GTPase binding,	IPR019137:Nck-associated protein 1,	hsa04810:Regulation of actin cytoskeleton,			R-HSA-2029482:R-HSA-2029482,R-HSA-4420097:R-HSA-4420097,R-HSA-5663213:R-HSA-5663213,		3D-structure,Acetylation,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Host-virus interaction,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Nck-associated protein 1,splice variant,transmembrane region,
ENSG00000103494	RPGRIP1 like(RPGRIP1L)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001736~establishment of planar polarity,GO:0001822~kidney development,GO:0001889~liver development,GO:0007163~establishment or maintenance of cell polarity,GO:0007368~determination of left/right symmetry,GO:0008589~regulation of smoothened signaling pathway,GO:0021532~neural tube patterning,GO:0021549~cerebellum development,GO:0021670~lateral ventricle development,GO:0021772~olfactory bulb development,GO:0022038~corpus callosum development,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0042384~cilium assembly,GO:0043010~camera-type eye development,GO:0043584~nose development,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0060039~pericardium development,GO:0060271~cilium morphogenesis,GO:0090102~cochlea development,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0005929~cilium,GO:0005930~axoneme,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0031870~thromboxane A2 receptor binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR021656:Protein of unknown function DUF3250,		216360~COACH syndrome,611560~Joubert syndrome 7,611561~Meckel syndrome 5,		R-HSA-5610787:R-HSA-5610787,R-HSA-5620912:R-HSA-5620912,	SM00239:C2,	3D-structure,Alternative splicing,Cell junction,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Joubert syndrome,Meckel syndrome,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tight junction,	chain:Protein fantom,domain:C2 1,domain:C2 2,helix,sequence conflict,sequence variant,splice variant,strand,
ENSG00000101342	TBC/LysM-associated domain containing 2(TLDC2)	Homo sapiens							IPR006571:TLDc,					SM00584:TLDc,	Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C20orf118,compositionally biased region:Poly-Glu,domain:TLD,sequence variant,
ENSG00000204634	TBC1 domain family member 8(TBC1D8)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0008015~blood circulation,GO:0008284~positive regulation of cell proliferation,GO:0031338~regulation of vesicle fusion,GO:0090630~activation of GTPase activity,GO:1902017~regulation of cilium assembly,	GO:0005622~intracellular,GO:0012505~endomembrane system,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0017137~Rab GTPase binding,	IPR000195:Rab-GTPase-TBC domain,IPR004182:GRAM,IPR011992:EF-hand-like domain,					SM00164:TBC,SM00568:GRAM,	Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:TBC1 domain family member 8,domain:GRAM 1,domain:GRAM 2,domain:Rab-GAP TBC,sequence conflict,sequence variant,splice variant,
ENSG00000170017	activated leukocyte cell adhesion molecule(ALCAM)	Homo sapiens				GO:0002250~adaptive immune response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0008045~motor neuron axon guidance,GO:0031290~retinal ganglion cell axon guidance,GO:0048846~axon extension involved in axon guidance,GO:1990138~neuron projection extension,	GO:0001772~immunological synapse,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031226~intrinsic component of plasma membrane,GO:0042101~T cell receptor complex,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			R-HSA-373760:R-HSA-373760,	SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:CD166 antigen,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000177076	alkaline ceramidase 2(ACER2)	Homo sapiens				GO:0001953~negative regulation of cell-matrix adhesion,GO:0006672~ceramide metabolic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0008284~positive regulation of cell proliferation,GO:0010942~positive regulation of cell death,GO:0030148~sphingolipid biosynthetic process,GO:0032526~response to retinoic acid,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0035690~cellular response to drug,GO:0046512~sphingosine biosynthetic process,GO:0090285~negative regulation of protein glycosylation in Golgi,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,	GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0017040~ceramidase activity,GO:0071633~dihydroceramidase activity,	IPR008901:Ceramidase,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,			R-HSA-1660661:R-HSA-1660661,		Alternative splicing,Complete proteome,Glycoprotein,Golgi apparatus,Hydrolase,Lipid metabolism,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Alkaline ceramidase 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000155749	amyotrophic lateral sclerosis 2 chromosome region candidate 12(ALS2CR12)	Homo sapiens				GO:0043087~regulation of GTPase activity,	GO:0001520~outer dense fiber,GO:0005737~cytoplasm,GO:0035686~sperm fibrous sheath,	GO:0005515~protein binding,	IPR026674:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,						Acetylation,Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,modified residue,sequence variant,
ENSG00000239388	ankyrin repeat and SOCS box containing 14(ASB14)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0031625~ubiquitin protein ligase binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				R-HSA-983168:R-HSA-983168,	SM00248:ANK,SM00253:SOCS,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Reference proteome,Repeat,Signal,	chain:Ankyrin repeat and SOCS box protein 14,domain:SOCS box,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,splice variant,
ENSG00000145700	ankyrin repeat domain 31(ANKRD31)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,					SM00248:ANK,	ANK repeat,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 31,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,sequence variant,
ENSG00000116985	bone morphogenetic protein 8b(BMP8B)	Homo sapiens				GO:0001501~skeletal system development,GO:0001503~ossification,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0030509~BMP signaling pathway,GO:0040007~growth,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0051216~cartilage development,GO:0060395~SMAD protein signal transduction,	GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0008083~growth factor activity,GO:0070700~BMP receptor binding,	IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR002405:Inhibin, alpha subunit,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,				SM00204:TGFB,	Alternative splicing,Chondrogenesis,Complete proteome,Cytokine,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Growth factor,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Bone morphogenetic protein 8B,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000180881	calcyphosine 2(CAPS2)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,					SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Calcyphosin-2,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,sequence conflict,sequence variant,splice variant,
ENSG00000103888	cell migration inducing hyaluronan binding protein(CEMIP)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0030213~hyaluronan biosynthetic process,GO:0030214~hyaluronan catabolic process,GO:0030335~positive regulation of cell migration,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0090314~positive regulation of protein targeting to membrane,GO:1900020~positive regulation of protein kinase C activity,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0030665~clathrin-coated vesicle membrane,	GO:0004415~hyalurononglucosaminidase activity,GO:0005515~protein binding,GO:0005540~hyaluronic acid binding,GO:0032050~clathrin heavy chain binding,GO:0046923~ER retention sequence binding,	IPR011050:Pectin lyase fold/virulence factor,IPR012334:Pectin lyase fold,IPR019316:G8 domain,IPR025155:WxxW domain,				R-HSA-2142850:R-HSA-2142850,	SM01225:SM01225,	Alternative splicing,Cell membrane,Coated pit,Complete proteome,Cytoplasm,Endoplasmic reticulum,Glycoprotein,Glycosidase,Hyaluronic acid,Hydrolase,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Protein KIAA1199,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:PbH1 1,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000166446	chromodomain Y-like 2(CDYL2)	Homo sapiens			Lipid metabolism,	GO:0008152~metabolic process,	GO:0005634~nucleus,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0035064~methylated histone binding,	IPR000953:Chromo domain/shadow,IPR001753:Crotonase superfamily,IPR016197:Chromo domain-like,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,					SM00298:CHROMO,	3D-structure,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Chromodomain Y-like protein 2,domain:Chromo,sequence conflict,
ENSG00000188277	chromosome 15 open reading frame 62(C15orf62)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,GO:0017049~GTP-Rho binding,							Complete proteome,Mitochondrion,Reference proteome,Transit peptide,	chain:Uncharacterized protein C15orf62, mitochondrial,transit peptide:Mitochondrion,
ENSG00000187699	chromosome 2 open reading frame 88(C2orf88)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0034237~protein kinase A regulatory subunit binding,							3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Lipoprotein,Membrane,Myristate,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein FLJ90687,chain:UPF0733 protein C2orf88,lipid moiety-binding region:N-myristoyl glycine,modified residue,sequence variant,signal peptide,
ENSG00000234511	chromosome 5 open reading frame 58(C5orf58)	Homo sapiens													Complete proteome,Reference proteome,
ENSG00000130783	coiled-coil domain containing 62(CCDC62)	Homo sapiens				GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071392~cellular response to estradiol stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,							Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Polymorphism,Reference proteome,Repeat,	chain:Coiled-coil domain-containing protein 60,sequence conflict,sequence variant,splice variant,
ENSG00000106804	complement C5(C5)	Homo sapiens		h_alternativePathway:Alternative Complement Pathway,h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lectinPathway:Lectin Induced Complement Pathway,		GO:0000187~activation of MAPK activity,GO:0001701~in utero embryonic development,GO:0006935~chemotaxis,GO:0006950~response to stress,GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010760~negative regulation of macrophage chemotaxis,GO:0010951~negative regulation of endopeptidase activity,GO:0019835~cytolysis,GO:0030449~regulation of complement activation,GO:0045766~positive regulation of angiogenesis,GO:0060326~cell chemotaxis,GO:0090197~positive regulation of chemokine secretion,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0004866~endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008009~chemokine activity,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05150:Staphylococcus aureus infection,hsa05168:Herpes simplex infection,hsa05322:Systemic lupus erythematosus,	609536~C5 deficiency,615749~Eculizumab, poor response to,		R-HSA-166665:R-HSA-166665,R-HSA-174577:R-HSA-174577,R-HSA-375276:R-HSA-375276,R-HSA-418594:R-HSA-418594,R-HSA-977606:R-HSA-977606,	SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	3D-structure,Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Cytolysis,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Membrane attack complex,Polymorphism,Reference proteome,Secreted,Signal,	chain:C5a anaphylatoxin,chain:Complement C5 alpha chain,chain:Complement C5 alpha' chain,chain:Complement C5 beta chain,disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
ENSG00000080200	crystallin beta-gamma domain containing 3(CRYBG3)	Homo sapiens						GO:0030246~carbohydrate binding,	IPR000772:Ricin B lectin domain,IPR001064:Beta/gamma crystallin,IPR011024:Gamma-crystallin-related,					SM00247:XTALbg,SM00458:RICIN,	Alternative splicing,Complete proteome,Lectin,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Beta/gamma crystallin domain-containing protein 3,domain:Beta/gamma crystallin 'Greek key' 1,domain:Beta/gamma crystallin 'Greek key' 2,domain:Beta/gamma crystallin 'Greek key' 3,domain:Beta/gamma crystallin 'Greek key' 4,domain:Beta/gamma crystallin 'Greek key' 5,domain:Beta/gamma crystallin 'Greek key' 6,domain:Beta/gamma crystallin 'Greek key' 7,domain:Beta/gamma crystallin 'Greek key' 8,domain:Beta/gamma crystallin 'Greek key' 9,domain:Ricin B-type lectin,sequence conflict,sequence variant,splice variant,
ENSG00000008086	cyclin dependent kinase like 5(CDKL5)	Homo sapiens				GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0043547~positive regulation of GTPase activity,GO:0045773~positive regulation of axon extension,GO:0046777~protein autophosphorylation,GO:0050773~regulation of dendrite development,GO:0050775~positive regulation of dendrite morphogenesis,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032587~ruffle membrane,GO:0032839~dendrite cytoplasm,GO:0044294~dendritic growth cone,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0048365~Rac GTPase binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,		300672~Epileptic encephalopathy, early infantile, 2,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Chromosomal rearrangement,Complete proteome,Disease mutation,Epilepsy,Kinase,Mental retardation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cyclin-dependent kinase-like 5,compositionally biased region:Poly-Lys,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
ENSG00000188215	defective in cullin neddylation 1 domain containing 3(DCUN1D3)	Homo sapiens				GO:0010225~response to UV-C,GO:0010332~response to gamma radiation,GO:0030308~negative regulation of cell growth,GO:0043065~positive regulation of apoptotic process,GO:0045116~protein neddylation,GO:0051443~positive regulation of ubiquitin-protein transferase activity,	GO:0000151~ubiquitin ligase complex,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0031624~ubiquitin conjugating enzyme binding,GO:0032182~ubiquitin-like protein binding,GO:0097602~cullin family protein binding,	IPR005176:Potentiating neddylation domain,IPR014764:Defective-in-cullin neddylation protein,						3D-structure,Cell membrane,Complete proteome,Lipoprotein,Membrane,Myristate,Polymorphism,Reference proteome,	chain:DCN1-like protein 3,domain:DCUN1,
ENSG00000178904	dpy-19 like 3 (C. elegans)(DPY19L3)	Homo sapiens				GO:0018406~protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,	GO:0005637~nuclear inner membrane,GO:0016021~integral component of membrane,	GO:0000030~mannosyltransferase activity,	IPR018732:Dpy-19,						Alternative splicing,Complete proteome,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Protein dpy-19 homolog 3,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000198018	ectonucleoside triphosphate diphosphohydrolase 7(ENTPD7)	Homo sapiens					GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000407:Nucleoside phosphatase GDA1/CD39,						Calcium,Complete proteome,Cytoplasmic vesicle,Disulfide bond,Glycoprotein,Hydrolase,Magnesium,Membrane,Metal-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Ectonucleoside triphosphate diphosphohydrolase 7,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
ENSG00000038358	enhancer of mRNA decapping 4(EDC4)	Homo sapiens				GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	hsa03018:RNA degradation,			R-HSA-430039:R-HSA-430039,	SM00320:WD40,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Enhancer of mRNA-decapping protein 4,compositionally biased region:Ser-rich,modified residue,region of interest:Sufficient for nuclear localization,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,sequence conflict,splice variant,
ENSG00000167695	family with sequence similarity 57 member A(FAM57A)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR006634:TRAM/LAG1/CLN8 homology domain,					SM00724:TLC,	Alternative splicing,Cell membrane,Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM57A,domain:TLC,sequence conflict,splice variant,transmembrane region,
ENSG00000170271	fatty acid hydroxylase domain containing 2(FAXDC2)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0000254~C-4 methylsterol oxidase activity,GO:0005506~iron ion binding,	IPR006694:Fatty acid hydroxylase,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C5orf4,modified residue,sequence variant,transmembrane region,
ENSG00000157827	formin like 2(FMNL2)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0022604~regulation of cell morphogenesis,GO:0030866~cortical actin cytoskeleton organization,GO:0098609~cell-cell adhesion,	GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,	GO:0003779~actin binding,GO:0017048~Rho GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR010472:Diaphanous FH3,IPR010473:Diaphanous GTPase-binding,IPR014767:Diaphanous autoregulatory,IPR014768:GTPase-binding/formin homology 3,IPR015425:Actin-binding FH2,IPR016024:Armadillo-type fold,IPR017987:Wilm's tumour protein,				R-HSA-5663220:R-HSA-5663220,	SM00498:FH2,SM01139:SM01139,SM01140:SM01140,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Lipoprotein,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Formin-like protein 2,compositionally biased region:Pro-rich,domain:DAD,domain:FH2,domain:GBD/FH3,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000157017	ghrelin and obestatin prepropeptide(GHRL)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0000187~activation of MAPK activity,GO:0001696~gastric acid secretion,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006006~glucose metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008154~actin polymerization or depolymerization,GO:0008343~adult feeding behavior,GO:0009725~response to hormone,GO:0009755~hormone-mediated signaling pathway,GO:0016358~dendrite development,GO:0016525~negative regulation of angiogenesis,GO:0030252~growth hormone secretion,GO:0032024~positive regulation of insulin secretion,GO:0032095~regulation of response to food,GO:0032100~positive regulation of appetite,GO:0032691~negative regulation of interleukin-1 beta production,GO:0040013~negative regulation of locomotion,GO:0040018~positive regulation of multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0042322~negative regulation of circadian sleep/wake cycle, REM sleep,GO:0042536~negative regulation of tumor necrosis factor biosynthetic process,GO:0043066~negative regulation of apoptotic process,GO:0043400~cortisol secretion,GO:0043627~response to estrogen,GO:0045409~negative regulation of interleukin-6 biosynthetic process,GO:0046010~positive regulation of circadian sleep/wake cycle, non-REM sleep,GO:0046676~negative regulation of insulin secretion,GO:0046697~decidualization,GO:0050728~negative regulation of inflammatory response,GO:0051216~cartilage development,GO:0051461~positive regulation of corticotropin secretion,GO:0051464~positive regulation of cortisol secretion,GO:0051965~positive regulation of synapse assembly,GO:0060079~excitatory postsynaptic potential,GO:0060124~positive regulation of growth hormone secretion,GO:0060399~positive regulation of growth hormone receptor signaling pathway,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:2000506~negative regulation of energy homeostasis,GO:2000507~positive regulation of energy homeostasis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0030424~axon,GO:0034774~secretory granule lumen,GO:0098794~postsynapse,	GO:0001664~G-protein coupled receptor binding,GO:0005515~protein binding,GO:0016608~growth hormone-releasing hormone activity,GO:0030296~protein tyrosine kinase activator activity,GO:0031768~ghrelin receptor binding,	IPR005441:Preproghrelin peptide,IPR006737:Motilin/ghrelin-associated peptide,IPR006738:Motilin/ghrelin,	hsa04024:cAMP signaling pathway,	601665~Obesity, susceptibility to,		R-HSA-375276:R-HSA-375276,R-HSA-416476:R-HSA-416476,R-HSA-422085:R-HSA-422085,		3D-structure,Alternative splicing,Amidation,Complete proteome,Direct protein sequencing,Hormone,Lipoprotein,Polymorphism,Reference proteome,Secreted,Signal,	helix,lipid moiety-binding region:O-decanoyl serine; alternate,lipid moiety-binding region:O-octanoyl serine; alternate,modified residue,peptide:Ghrelin-27,peptide:Ghrelin-28,peptide:Obestatin,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,strand,
ENSG00000198785	glutamate ionotropic receptor NMDA type subunit 3A(GRIN3A)	Homo sapiens				GO:0006816~calcium ion transport,GO:0016358~dendrite development,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0045471~response to ethanol,GO:0060134~prepulse inhibition,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0017146~NMDA selective glutamate receptor complex,GO:0030054~cell junction,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0004972~NMDA glutamate receptor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005262~calcium channel activity,GO:0005515~protein binding,GO:0016594~glycine binding,GO:0042802~identical protein binding,GO:0051721~protein phosphatase 2A binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,hsa05034:Alcoholism,				SM00079:PBPe,SM00918:SM00918,	Calcium,Cell junction,Cell membrane,Coiled coil,Complete proteome,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Magnesium,Membrane,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Glutamate [NMDA] receptor subunit 3A,glycosylation site:N-linked (GlcNAc...),region of interest:PPP2CB binding site,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000176153	glutathione peroxidase 2(GPX2)	Homo sapiens				GO:0000302~response to reactive oxygen species,GO:0006979~response to oxidative stress,GO:0055114~oxidation-reduction process,GO:0098869~cellular oxidant detoxification,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004602~glutathione peroxidase activity,GO:0009055~electron carrier activity,	IPR000889:Glutathione peroxidase,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00590:Arachidonic acid metabolism,hsa04918:Thyroid hormone synthesis,		PIRSF000303:glutathione peroxidase,	R-HSA-2142688:R-HSA-2142688,R-HSA-2142712:R-HSA-2142712,R-HSA-2142770:R-HSA-2142770,R-HSA-3299685:R-HSA-3299685,R-HSA-5628897:R-HSA-5628897,		3D-structure,Complete proteome,Cytoplasm,Oxidoreductase,Peroxidase,Polymorphism,Proteomics identification,Reference proteome,Selenocysteine,	chain:Glutathione peroxidase 2,helix,sequence conflict,sequence variant,strand,turn,
ENSG00000112293	glycosylphosphatidylinositol specific phospholipase D1(GPLD1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0001503~ossification,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0002062~chondrocyte differentiation,GO:0002430~complement receptor mediated signaling pathway,GO:0006507~GPI anchor release,GO:0008285~negative regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0009749~response to glucose,GO:0010595~positive regulation of endothelial cell migration,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0010867~positive regulation of triglyceride biosynthetic process,GO:0010897~negative regulation of triglyceride catabolic process,GO:0010907~positive regulation of glucose metabolic process,GO:0010983~positive regulation of high-density lipoprotein particle clearance,GO:0032869~cellular response to insulin stimulus,GO:0035690~cellular response to drug,GO:0035701~hematopoietic stem cell migration,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0043065~positive regulation of apoptotic process,GO:0045919~positive regulation of cytolysis,GO:0046470~phosphatidylcholine metabolic process,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051047~positive regulation of secretion,GO:0070633~transepithelial transport,GO:0071277~cellular response to calcium ion,GO:0071397~cellular response to cholesterol,GO:0071401~cellular response to triglyceride,GO:0071467~cellular response to pH,GO:0097241~hematopoietic stem cell migration to bone marrow,GO:1900076~regulation of cellular response to insulin stimulus,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004621~glycosylphosphatidylinositol phospholipase D activity,GO:0004630~phospholipase D activity,GO:0017080~sodium channel regulator activity,	IPR001028:Glycoprotein phospholipase D,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,	hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,				SM00191:Int_alpha,	Alternative splicing,Complete proteome,Direct protein sequencing,Glycoprotein,Hydrolase,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Phosphatidylinositol-glycan-specific phospholipase D,glycosylation site:N-linked (GlcNAc...),repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000148935	growth arrest specific 2(GAS2)	Homo sapiens		h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,		GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0008360~regulation of cell shape,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0016020~membrane,	GO:0008017~microtubule binding,	IPR001715:Calponin homology domain,IPR003108:Growth-arrest-specific protein 2 domain,				R-HSA-264870:R-HSA-264870,	SM00033:CH,SM00243:GAS2,	Alternative splicing,Apoptosis,Cell cycle,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Growth arrest,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Growth arrest-specific protein 2,domain:CH,modified residue,site:Cleavage; by a caspase during apoptosis,
ENSG00000138448	integrin subunit alpha V(ITGAV)	Homo sapiens		h_edg1Pathway:Phospholipids as signalling intermediaries,		GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010888~negative regulation of lipid storage,GO:0016049~cell growth,GO:0016477~cell migration,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0031589~cell-substrate adhesion,GO:0032369~negative regulation of lipid transport,GO:0033627~cell adhesion mediated by integrin,GO:0033690~positive regulation of osteoblast proliferation,GO:0034113~heterotypic cell-cell adhesion,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0043277~apoptotic cell clearance,GO:0045715~negative regulation of low-density lipoprotein particle receptor biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0046718~viral entry into host cell,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0050748~negative regulation of lipoprotein metabolic process,GO:0050764~regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0050919~negative chemotaxis,GO:0052066~entry of symbiont into host cell by promotion of host phagocytosis,GO:0070371~ERK1 and ERK2 cascade,GO:0070588~calcium ion transmembrane transport,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2000425~regulation of apoptotic cell clearance,GO:2000536~negative regulation of entry of bacterium into host cell,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031258~lamellipodium membrane,GO:0031527~filopodium membrane,GO:0031528~microvillus membrane,GO:0032587~ruffle membrane,GO:0034683~integrin alphav-beta3 complex,GO:0034684~integrin alphav-beta5 complex,GO:0034686~integrin alphav-beta8 complex,GO:0035867~alphav-beta3 integrin-IGF-1-IGF1R complex,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001846~opsonin binding,GO:0001968~fibronectin binding,GO:0002020~protease binding,GO:0005080~protein kinase C binding,GO:0005245~voltage-gated calcium channel activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0017134~fibroblast growth factor binding,GO:0019960~C-X3-C chemokine binding,GO:0031994~insulin-like growth factor I binding,GO:0038132~neuregulin binding,GO:0046872~metal ion binding,GO:0050431~transforming growth factor beta binding,GO:0050840~extracellular matrix binding,GO:1990430~extracellular matrix protein binding,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04145:Phagosome,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa04810:Regulation of actin cytoskeleton,hsa04919:Thyroid hormone signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			R-HSA-1236973:R-HSA-1236973,R-HSA-1566948:R-HSA-1566948,R-HSA-210990:R-HSA-210990,R-HSA-2129379:R-HSA-2129379,R-HSA-216083:R-HSA-216083,R-HSA-3000157:R-HSA-3000157,R-HSA-3000170:R-HSA-3000170,R-HSA-3000178:R-HSA-3000178,R-HSA-4420097:R-HSA-4420097,R-HSA-445144:R-HSA-445144,	SM00191:Int_alpha,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cell junction,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Integrin,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-V,chain:Integrin alpha-V heavy chain,chain:Integrin alpha-V light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,short sequence motif:GFFKR motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000056736	interleukin 17 receptor B(IL17RB)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006952~defense response,GO:0019221~cytokine-mediated signaling pathway,GO:0050729~positive regulation of inflammatory response,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004896~cytokine receptor activity,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,	hsa04060:Cytokine-cytokine receptor interaction,					Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor B,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000243789	jumonji domain containing 7(JMJD7)	Homo sapiens						GO:0005515~protein binding,	IPR003347:JmjC domain,					SM00558:JmjC,	Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Cytosolic phospholipase A2 beta,chain:JmjC domain-containing protein 7,domain:C2,domain:JmjC,domain:PLA2c,mutagenesis site,sequence conflict,sequence variant,splice variant,
ENSG00000167216	katanin catalytic subunit A1 like 2(KATNAL2)	Homo sapiens				GO:0031122~cytoplasmic microtubule organization,GO:0051013~microtubule severing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008568~microtubule-severing ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR006594:LisH dimerisation motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,IPR027497:Katanin p60 ATPase-containing subunit A-like 2,					SM00382:AAA,SM00667:LisH,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Microtubule,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Katanin p60 ATPase-containing subunit A- like 2,domain:LisH,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
ENSG00000264058	keratin 222(KRT222)	Homo sapiens					GO:0005882~intermediate filament,	GO:0005198~structural molecule activity,	IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR018039:Intermediate filament protein, conserved site,						Alternative splicing,Coiled coil,Complete proteome,Intermediate filament,Keratin,Reference proteome,	chain:Keratin-like protein KRT222,splice variant,
ENSG00000138160	kinesin family member 11(KIF11)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007018~microtubule-based movement,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007100~mitotic centrosome separation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0046602~regulation of mitotic centrosome separation,GO:0051301~cell division,GO:0090307~mitotic spindle assembly,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0016020~membrane,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0019901~protein kinase binding,GO:0032403~protein complex binding,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR025901:Kinesin-associated microtubule-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		152950~Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation,		R-HSA-2132295:R-HSA-2132295,R-HSA-983189:R-HSA-983189,	SM00129:KISc,	3D-structure,Acetylation,ATP-binding,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Microtubule,Mitosis,Motor protein,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:Kinesin-like protein KIF11,domain:Kinesin-motor,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
ENSG00000184445	kinetochore associated 1(KNTC1)	Homo sapiens				GO:0006461~protein complex assembly,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0007096~regulation of exit from mitosis,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:1990423~RZZ complex,	GO:0005515~protein binding,	IPR017986:WD40-repeat-containing domain,IPR019527:RZZ complex, subunit KNTC1/ROD, C-terminal,				R-HSA-2467813:R-HSA-2467813,R-HSA-2500257:R-HSA-2500257,R-HSA-5663220:R-HSA-5663220,R-HSA-68877:R-HSA-68877,		Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinetochore-associated protein 1,modified residue,sequence variant,
ENSG00000238083	leucine rich repeat containing 37 member A2(LRRC37A2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR015753:Proline-rich Peptides,					SM00369:LRR_TYP,	Complete proteome,Glycoprotein,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat-containing protein 37A2,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000122477	leucine rich repeat containing 39(LRRC39)	Homo sapiens							IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR025875:Leucine rich repeat 4,					SM00369:LRR_TYP,	Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 39,compositionally biased region:Poly-Glu,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,splice variant,
ENSG00000072201	ligand of numb-protein X 1(LNX1)	Homo sapiens				GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0051260~protein homooligomerization,	GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0030165~PDZ domain binding,	IPR001478:PDZ domain,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,				R-HSA-983168:R-HSA-983168,	SM00184:RING,SM00228:PDZ,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Ligase,Metal-binding,Phosphoprotein,Reference proteome,Repeat,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase LNX,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,helix,sequence conflict,short sequence motif:NPXY motif,splice variant,strand,zinc finger region:RING-type,
ENSG00000134013	lysyl oxidase like 2(LOXL2)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001837~epithelial to mesenchymal transition,GO:0001935~endothelial cell proliferation,GO:0002040~sprouting angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0006898~receptor-mediated endocytosis,GO:0007155~cell adhesion,GO:0007568~aging,GO:0016570~histone modification,GO:0018277~protein deamination,GO:0030199~collagen fibril organization,GO:0032332~positive regulation of chondrocyte differentiation,GO:0043542~endothelial cell migration,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046688~response to copper ion,GO:0055114~oxidation-reduction process,	GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0004720~protein-lysine 6-oxidase activity,GO:0005044~scavenger receptor activity,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,GO:0035064~methylated histone binding,GO:0070492~oligosaccharide binding,	IPR001190:Speract/scavenger receptor,IPR001695:Lysyl oxidase,IPR017448:Speract/scavenger receptor-related,IPR019828:Lysyl oxidase, conserved site,				R-HSA-1566948:R-HSA-1566948,R-HSA-2243919:R-HSA-2243919,	SM00202:SR,	Basement membrane,Chromatin regulator,Chromosome,Complete proteome,Copper,Disulfide bond,Extracellular matrix,Glycoprotein,LTQ,Metal-binding,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Secreted,Signal,TPQ,Transcription,Transcription regulation,	chain:Lysyl oxidase homolog 2,cross-link:Lysine tyrosylquinone (Lys-Tyr),disulfide bond,domain:SRCR 1,domain:SRCR 2,domain:SRCR 3,domain:SRCR 4,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Copper,modified residue,region of interest:Lysyl-oxidase like,sequence conflict,sequence variant,signal peptide,
ENSG00000111885	mannosidase alpha class 1A member 1(MAN1A1)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,		GO:0006491~N-glycan processing,GO:1904381~Golgi apparatus mannose trimming,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,GO:0015923~mannosidase activity,	IPR001382:Glycoside hydrolase, family 47,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,hsa04141:Protein processing in endoplasmic reticulum,			R-HSA-964827:R-HSA-964827,		Alternative splicing,Calcium,Complete proteome,Disulfide bond,Glycoprotein,Glycosidase,Golgi apparatus,Hydrolase,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Mannosyl-oligosaccharide 1,2-alpha- mannosidase IA,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000145416	membrane associated ring-CH-type finger 1(MARCH1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0002495~antigen processing and presentation of peptide antigen via MHC class II,GO:0006955~immune response,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:0032588~trans-Golgi network membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0042287~MHC protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR011016:Zinc finger, RING-CH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,					SM00744:RINGv,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endosome,Golgi apparatus,Immunity,Ligase,Lysosome,Membrane,Metal-binding,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase MARCH1,splice variant,transmembrane region,zinc finger region:RING-CH-type,
ENSG00000177669	membrane bound O-acyltransferase domain containing 4(MBOAT4)	Homo sapiens				GO:0018191~peptidyl-serine octanoylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0008374~O-acyltransferase activity,GO:0016412~serine O-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR004299:Membrane bound O-acyl transferase, MBOAT,				R-HSA-422085:R-HSA-422085,		Acyltransferase,Alternative splicing,Complete proteome,Endoplasmic reticulum,Membrane,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Ghrelin O-acyltransferase,compositionally biased region:Poly-Leu,mutagenesis site,sequence variant,splice variant,transmembrane region,
ENSG00000196535	myosin XVIIIA(MYO18A)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0007030~Golgi organization,GO:0016477~cell migration,GO:0031032~actomyosin structure organization,GO:0043030~regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0048194~Golgi vesicle budding,GO:0050714~positive regulation of protein secretion,GO:0090161~Golgi ribbon formation,GO:0090164~asymmetric Golgi ribbon formation,GO:1903028~positive regulation of opsonization,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0016020~membrane,GO:0016459~myosin complex,GO:0042641~actomyosin,	GO:0003677~DNA binding,GO:0003774~motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0051015~actin filament binding,	IPR000048:IQ motif, EF-hand binding site,IPR001478:PDZ domain,IPR001609:Myosin head, motor domain,IPR002928:Myosin tail,IPR020587:DNA recombination/repair protein RecA, monomer-monomer interface,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				R-HSA-1839117:R-HSA-1839117,R-HSA-5655302:R-HSA-5655302,	SM00015:IQ,SM00228:PDZ,SM00242:MYSc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Motor protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,	chain:Myosin-XVIIIa,domain:IQ,domain:Myosin head-like,domain:PDZ,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:Interaction with actin,splice variant,
ENSG00000133392	myosin heavy chain 11(MYH11)	Homo sapiens				GO:0006936~muscle contraction,GO:0006939~smooth muscle contraction,GO:0030241~skeletal muscle myosin thick filament assembly,GO:0048251~elastic fiber assembly,GO:0048739~cardiac muscle fiber development,	GO:0005829~cytosol,GO:0005859~muscle myosin complex,GO:0016459~myosin complex,GO:0032982~myosin filament,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0003774~motor activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008307~structural constituent of muscle,GO:0051015~actin filament binding,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR002928:Myosin tail,IPR004009:Myosin, N-terminal, SH3-like,IPR008989:Myosin S1 fragment, N-terminal,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04530:Tight junction,	132900~Aortic aneurysm, familial thoracic 4,		R-HSA-3928663:R-HSA-3928663,R-HSA-416572:R-HSA-416572,R-HSA-445355:R-HSA-445355,R-HSA-5625740:R-HSA-5625740,R-HSA-5625900:R-HSA-5625900,R-HSA-5627117:R-HSA-5627117,R-HSA-5627123:R-HSA-5627123,	SM00015:IQ,SM00242:MYSc,	Actin-binding,Alternative splicing,Aortic aneurysm,ATP-binding,Calmodulin-binding,Chromosomal rearrangement,Coiled coil,Complete proteome,Disease mutation,Methylation,Motor protein,Muscle protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Thick filament,	chain:Myosin-11,domain:IQ,domain:Myosin head-like,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Actin-binding,region of interest:Carboxyl-terminal,sequence conflict,sequence variant,
ENSG00000003987	myotubularin related protein 7(MTMR7)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0046855~inositol phosphate dephosphorylation,GO:0046856~phosphatidylinositol dephosphorylation,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0052629~phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,GO:0052866~phosphatidylinositol phosphate phosphatase activity,	IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR004182:GRAM,IPR010569:Myotubularin-related,IPR011993:Pleckstrin homology-like domain,IPR016130:Protein-tyrosine phosphatase, active site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,			R-HSA-1660517:R-HSA-1660517,	SM00404:PTPc_motif,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Phosphoprotein,Polymorphism,Reference proteome,	active site:Phosphocysteine intermediate,binding site:Substrate,chain:Myotubularin-related protein 7,domain:Myotubularin phosphatase,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,
ENSG00000053438	neuronatin(NNAT)	Homo sapiens				GO:0006810~transport,GO:0007420~brain development,GO:0009249~protein lipoylation,GO:0030182~neuron differentiation,GO:0032024~positive regulation of insulin secretion,	GO:0005737~cytoplasm,		IPR024885:Neuronatin,						Alternative splicing,Complete proteome,Developmental protein,Reference proteome,	chain:Neuronatin,sequence conflict,splice variant,
ENSG00000087303	nidogen 2(NID2)	Homo sapiens				GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0030198~extracellular matrix organization,GO:0071711~basement membrane organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005518~collagen binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000716:Thyroglobulin type-1,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR003886:Nidogen, extracellular domain,IPR006605:G2 nidogen/fibulin G2F,IPR009017:Green fluorescent protein,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,IPR024731:EGF domain, merozoite surface protein 1-like,IPR026823:Complement Clr-like EGF domain,				R-HSA-3000157:R-HSA-3000157,	SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00211:TY,SM00539:NIDO,SM00682:G2F,	Alternative splicing,Basement membrane,Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Methylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Nidogen-2,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:NIDO,domain:Nidogen G2 beta-barrel,domain:Thyroglobulin type-1 1,domain:Thyroglobulin type-1 2,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,sequence conflict,sequence variant,signal peptide,
ENSG00000165030	nuclear factor, interleukin 3 regulated(NFIL3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007623~circadian rhythm,GO:0010628~positive regulation of gene expression,GO:0071353~cellular response to interleukin-4,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR004827:Basic-leucine zipper domain,IPR010533:Vertebrate interleukin-3 regulated transcription factor,IPR016743:Transcription factor, basic leucine zipper, E4BP4,			PIRSF019029:basic leucine zipper (bZIP) transcription factor E4BP4,		SM00338:BRLZ,	Activator,Biological rhythms,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear factor interleukin-3-regulated protein,compositionally biased region:Ser-rich,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,mutagenesis site,region of interest:Necessary for transcriptional repression and sufficient for interaction with DR1,sequence conflict,
ENSG00000053702	nuclear receptor interacting protein 2(NRIP2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006508~proteolysis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004190~aspartic-type endopeptidase activity,GO:0005515~protein binding,	IPR019103:Aspartic peptidase, DDI1-type,IPR021109:Aspartic peptidase,						Alternative splicing,Complete proteome,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Nuclear receptor-interacting protein 2,short sequence motif:LXXLL motif,
ENSG00000184792	oxysterol binding protein 2(OSBP2)	Homo sapiens				GO:0006869~lipid transport,GO:0007286~spermatid development,	GO:0016020~membrane,GO:0097440~apical dendrite,	GO:0005515~protein binding,GO:0015485~cholesterol binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,					SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Lipid transport,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Oxysterol-binding protein 2,domain:PH,sequence conflict,sequence variant,
ENSG00000178385	pleckstrin homology domain containing M3(PLEKHM3)	Homo sapiens						GO:0046872~metal ion binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR025258:Domain of unknown function DUF4206,					SM00233:PH,SM01175:SM01175,	Alternative splicing,Complete proteome,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Pleckstrin homology domain-containing family M member 3,compositionally biased region:Poly-Gln,domain:PH 1,domain:PH 2,modified residue,splice variant,zinc finger region:Phorbol-ester/DAG-type,
ENSG00000189266	proline rich nuclear receptor coactivator 2(PNRC2)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031087~deadenylation-independent decapping of nuclear-transcribed mRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,	GO:0005515~protein binding,	IPR026780:Proline-rich nuclear receptor coactivator 1/2,IPR026781:Proline-rich nuclear receptor coactivator 2,						3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Nonsense-mediated mRNA decay,Nucleus,Receptor,Reference proteome,Transcription,Transcription regulation,	chain:Proline-rich nuclear receptor coactivator 2,mutagenesis site,short sequence motif:SH3-binding,splice variant,
ENSG00000116690	proteoglycan 4(PRG4)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0008283~cell proliferation,	GO:0005576~extracellular region,	GO:0005044~scavenger receptor activity,GO:0030247~polysaccharide binding,	IPR000585:Hemopexin-like domain,IPR001212:Somatomedin B domain,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR020436:Somatomedin B, chordata,		208250~Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,			SM00120:HX,SM00201:SO,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Proteoglycan 4,chain:Proteoglycan 4 C-terminal part,compositionally biased region:Ser-rich,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:SMB 1,domain:SMB 2,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:59 X 8 AA repeats of K-X-P-X-P-T-T-X,repeat:1,repeat:10,repeat:11; approximate,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16; approximate,repeat:17,repeat:18; approximate,repeat:19; approximate,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24; approximate,repeat:25,repeat:26; approximate,repeat:27,repeat:28,repeat:29,repeat:2; approximate,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33; approximate,repeat:34,repeat:35; approximate,repeat:36; approximate,repeat:37; approximate,repeat:38; approximate,repeat:39,repeat:40,repeat:41,repeat:42; approximate,repeat:43; approximate,repeat:44,repeat:45; approximate,repeat:46; approximate,repeat:47; approximate,repeat:48; approximate,repeat:49,repeat:4; approximate,repeat:5,repeat:50,repeat:51; approximate,repeat:52,repeat:53; approximate,repeat:54; approximate,repeat:55; approximate,repeat:56; approximate,repeat:57,repeat:58,repeat:59; approximate,repeat:6; approximate,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,signal peptide,site:Cleavage; by subtilisin-like proprotein convertase 4,splice variant,
ENSG00000121039	retinol dehydrogenase 10 (all-trans)(RDH10)	Homo sapiens			General function prediction only,	GO:0001523~retinoid metabolic process,GO:0001656~metanephros development,GO:0001701~in utero embryonic development,GO:0002138~retinoic acid biosynthetic process,GO:0007601~visual perception,GO:0008406~gonad development,GO:0014032~neural crest cell development,GO:0031076~embryonic camera-type eye development,GO:0035115~embryonic forelimb morphogenesis,GO:0042572~retinol metabolic process,GO:0042574~retinal metabolic process,GO:0043583~ear development,GO:0043584~nose development,GO:0048703~embryonic viscerocranium morphogenesis,GO:0055114~oxidation-reduction process,GO:0060431~primary lung bud formation,GO:0060449~bud elongation involved in lung branching,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044297~cell body,	GO:0004745~retinol dehydrogenase activity,GO:0052650~NADP-retinol dehydrogenase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,			R-HSA-2453902:R-HSA-2453902,R-HSA-5365859:R-HSA-5365859,		Complete proteome,Endoplasmic reticulum,Membrane,Microsome,NADP,Oxidoreductase,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Substrate,chain:Retinol dehydrogenase 10,nucleotide phosphate-binding region:NADP,transmembrane region,
ENSG00000162437	ribonucleoprotein, PTB binding 2(RAVER2)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,					SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Ribonucleoprotein PTB-binding 2,compositionally biased region:Ala/Gly-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,splice variant,strand,
ENSG00000116514	ring finger protein 19B(RNF19B)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0002250~adaptive immune response,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0044194~cytolytic granule,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031624~ubiquitin conjugating enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR002867:Zinc finger, C6HC-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				R-HSA-983168:R-HSA-983168,	SM00184:RING,SM00647:IBR,	Adaptive immunity,Alternative splicing,Complete proteome,Immunity,Membrane,Metal-binding,Reference proteome,Repeat,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RNF19B,compositionally biased region:Ala-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,sequence conflict,splice variant,transmembrane region,zinc finger region:IBR-type,zinc finger region:RING-type 1,zinc finger region:RING-type 2,
ENSG00000105982	ring finger protein 32(RNF32)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,		GO:0005768~endosome,GO:0016235~aggresome,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000048:IQ motif, EF-hand binding site,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR027370:RING-type zinc-finger, LisH dimerisation motif,					SM00184:RING,	Alternative splicing,Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:RING finger protein 32,domain:IQ,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type 1; atypical,zinc finger region:RING-type 2; atypical,
ENSG00000163406	solute carrier family 15 member 2(SLC15A2)	Homo sapiens				GO:0006810~transport,GO:0006811~ion transport,GO:0006857~oligopeptide transport,GO:0015031~protein transport,GO:0015893~drug transport,GO:0015992~proton transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0015198~oligopeptide transporter activity,GO:0015333~peptide:proton symporter activity,	IPR000109:Proton-dependent oligopeptide transporter family,IPR004768:Oligopeptide transporter,IPR018456:PTR2 family proton/oligopeptide symporter, conserved site,IPR020846:Major facilitator superfamily domain,				R-HSA-427975:R-HSA-427975,		Alternative splicing,Complete proteome,Glycoprotein,Membrane,Peptide transport,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 15 member 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
ENSG00000170482	solute carrier family 23 member 1(SLC23A1)	Homo sapiens		h_vitCBPathway:Vitamin C in the Brain,		GO:0006139~nucleobase-containing compound metabolic process,GO:0006814~sodium ion transport,GO:0007420~brain development,GO:0009636~response to toxic substance,GO:0015851~nucleobase transport,GO:0015882~L-ascorbic acid transport,GO:0019852~L-ascorbic acid metabolic process,GO:0030324~lung development,GO:0035461~vitamin transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0070837~dehydroascorbic acid transport,GO:0070904~transepithelial L-ascorbic acid transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0043229~intracellular organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008520~L-ascorbate:sodium symporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015205~nucleobase transmembrane transporter activity,GO:0015229~L-ascorbic acid transporter activity,GO:0033300~dehydroascorbic acid transporter activity,GO:0070890~sodium-dependent L-ascorbate transmembrane transporter activity,	IPR006043:Xanthine/uracil/vitamin C permease,				R-HSA-196836:R-HSA-196836,		Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 23 member 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000074621	solute carrier family 24 member 1(SLC24A1)	Homo sapiens				GO:0006810~transport,GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0007601~visual perception,GO:0009642~response to light intensity,GO:0035725~sodium ion transmembrane transport,GO:0055085~transmembrane transport,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0019867~outer membrane,	GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008273~calcium, potassium:sodium antiporter activity,GO:0015293~symporter activity,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,	IPR004481:Sodium/potassium/calcium exchanger,IPR004817:K+-dependent Na+/Ca+ exchanger,IPR004837:Sodium/calcium exchanger membrane region,	hsa04744:Phototransduction,	613830~Night blindness, congenital stationary (complete), 1D, autosomal recessive,		R-HSA-2485179:R-HSA-2485179,R-HSA-425561:R-HSA-425561,R-HSA-5619077:R-HSA-5619077,		Alternative splicing,Antiport,Calcium,Calcium transport,Coiled coil,Complete proteome,Congenital stationary night blindness,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sensory transduction,Signal,Symport,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Sodium/potassium/calcium exchanger 1,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:Alpha-1,repeat:Alpha-2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000076351	solute carrier family 46 member 1(SLC46A1)	Homo sapiens				GO:0006879~cellular iron ion homeostasis,GO:0015884~folic acid transport,GO:0015886~heme transport,GO:0046655~folic acid metabolic process,GO:0051958~methotrexate transport,GO:0055085~transmembrane transport,GO:0098829~intestinal folate absorption,GO:1902600~hydrogen ion transmembrane transport,GO:1904447~folic acid import into cell,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,	GO:0005215~transporter activity,GO:0005542~folic acid binding,GO:0008517~folic acid transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015232~heme transporter activity,GO:0015350~methotrexate transporter activity,	IPR005829:Sugar transporter, conserved site,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,		229050~Folate malabsorption, hereditary,		R-HSA-196757:R-HSA-196757,R-HSA-917937:R-HSA-917937,		Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Folate-binding,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Proton-coupled folate transporter,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000130821	solute carrier family 6 member 8(SLC6A8)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,		General function prediction only,	GO:0006600~creatine metabolic process,GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0006936~muscle contraction,GO:0015881~creatine transport,GO:0035725~sodium ion transmembrane transport,GO:1902598~creatine transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005308~creatine transmembrane transporter activity,GO:0005309~creatine:sodium symporter activity,GO:0005328~neurotransmitter:sodium symporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002984:Sodium:neurotransmitter symporter, creatine,		300352~Cerebral creatine deficiency syndrome 1,		R-HSA-71288:R-HSA-71288,		Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent creatine transporter 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000136206	speedy/RINGO cell cycle regulator family member E1(SPDYE1)	Homo sapiens				GO:0045859~regulation of protein kinase activity,		GO:0019901~protein kinase binding,	IPR020984:Cell cycle regulatory protein, Spy1,						Complete proteome,Reference proteome,Williams-Beuren syndrome,	chain:Putative Speedy protein E5,chain:Speedy protein E1,compositionally biased region:Arg-rich,sequence conflict,
ENSG00000163082	sphingosine-1-phosphate phosphatase 2(SGPP2)	Homo sapiens				GO:0006670~sphingosine metabolic process,GO:0016311~dephosphorylation,GO:0030148~sphingolipid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0042392~sphingosine-1-phosphate phosphatase activity,GO:0070780~dihydrosphingosine-1-phosphate phosphatase activity,	IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase,	hsa00600:Sphingolipid metabolism,hsa04071:Sphingolipid signaling pathway,			R-HSA-1660661:R-HSA-1660661,	SM00014:acidPPc,	Alternative splicing,Complete proteome,Endoplasmic reticulum,Hydrolase,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sphingosine-1-phosphate phosphatase 2,transmembrane region,
ENSG00000169962	taste 1 receptor member 3(TAS1R3)	Homo sapiens				GO:0001582~detection of chemical stimulus involved in sensory perception of sweet taste,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050916~sensory perception of sweet taste,GO:0050917~sensory perception of umami taste,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:1903767~sweet taste receptor complex,	GO:0004930~G-protein coupled receptor activity,GO:0008527~taste receptor activity,GO:0033041~sweet taste receptor activity,GO:0046982~protein heterodimerization activity,	IPR000337:GPCR, family 3,IPR001828:Extracellular ligand-binding receptor,IPR011500:GPCR, family 3, nine cysteines domain,IPR017978:GPCR, family 3, C-terminal,IPR017979:GPCR, family 3, conserved site,	hsa04742:Taste transduction,hsa04973:Carbohydrate digestion and absorption,			R-HSA-420499:R-HSA-420499,		Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Sensory transduction,Signal,Taste,Transducer,Transmembrane,Transmembrane helix,	chain:Taste receptor type 1 member 3,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Required for brazzein responsiveness,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000259431	thiamine triphosphatase(THTPA)	Homo sapiens				GO:0006091~generation of precursor metabolites and energy,GO:0006772~thiamine metabolic process,GO:0016311~dephosphorylation,GO:0042357~thiamine diphosphate metabolic process,GO:0042723~thiamine-containing compound metabolic process,	GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0016787~hydrolase activity,GO:0050333~thiamin-triphosphatase activity,	IPR012177:Thiamine triphosphatase,IPR023577:CYTH-like domain,	hsa00730:Thiamine metabolism,hsa01100:Metabolic pathways,		PIRSF036561:thiamine triphosphatase,	R-HSA-196819:R-HSA-196819,	SM01118:SM01118,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Thiamine-triphosphatase,helix,modified residue,sequence variant,strand,
ENSG00000113296	thrombospondin 4(THBS4)	Homo sapiens				GO:0001938~positive regulation of endothelial cell proliferation,GO:0006986~response to unfolded protein,GO:0007155~cell adhesion,GO:0016525~negative regulation of angiogenesis,GO:0034103~regulation of tissue remodeling,GO:0034976~response to endoplasmic reticulum stress,GO:0048266~behavioral response to pain,GO:0048771~tissue remodeling,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051451~myoblast migration,GO:0051781~positive regulation of cell division,GO:0071603~endothelial cell-cell adhesion,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0016529~sarcoplasmic reticulum,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,	IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR003367:Thrombospondin, type 3-like repeat,IPR008859:Thrombospondin, C-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017897:Thrombospondin, type 3 repeat,IPR018097:EGF-like calcium-binding, conserved site,IPR024665:Thrombospondin/cartilage oligomeric matrix protein, coiled-coil domain,	hsa04145:Phagosome,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05144:Malaria,			R-HSA-186797:R-HSA-186797,	SM00179:EGF_CA,SM00181:EGF,SM00210:TSPN,	Calcium,Cell adhesion,Complete proteome,Disulfide bond,EGF-like domain,Endoplasmic reticulum,Extracellular matrix,Glycoprotein,Growth factor,Mitogen,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sarcoplasmic reticulum,Secreted,Signal,Tissue remodeling,Unfolded protein response,	chain:Thrombospondin-4,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:TSP C-terminal,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),repeat:TSP type-3 1,repeat:TSP type-3 2,repeat:TSP type-3 3,repeat:TSP type-3 4,repeat:TSP type-3 5,repeat:TSP type-3 6,repeat:TSP type-3 7,repeat:TSP type-3 8,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,
ENSG00000205269	transmembrane protein 170B(TMEM170B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR019334:Transmembrane protein 170,						Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 170B,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000184979	ubiquitin specific peptidase 18(USP18)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,GO:0060338~regulation of type I interferon-mediated signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0019785~ISG15-specific protease activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,				R-HSA-1169408:R-HSA-1169408,R-HSA-912694:R-HSA-912694,		Alternative initiation,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Polymorphism,Protease,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubl carboxyl-terminal hydrolase 18,sequence conflict,sequence variant,
ENSG00000103404	ubiquitin specific peptidase 31(USP31)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,	GO:0005634~nucleus,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,						Alternative splicing,Complete proteome,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 31,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000166348	ubiquitin specific peptidase 54(USP54)	Homo sapiens				GO:0016579~protein deubiquitination,		GO:0005515~protein binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR007330:MIT,						Alternative splicing,Coiled coil,Complete proteome,Hydrolase,Methylation,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,	chain:Inactive ubiquitin carboxyl-terminal hydrolase 54,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000180233	zinc and ring finger 2(ZNRF2)	Homo sapiens				GO:0000209~protein polyubiquitination,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0030054~cell junction,GO:0030659~cytoplasmic vesicle membrane,GO:0042734~presynaptic membrane,GO:0043234~protein complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				R-HSA-983168:R-HSA-983168,	SM00184:RING,	Cell junction,Cell membrane,Complete proteome,Endosome,Ligase,Lipoprotein,Lysosome,Membrane,Metal-binding,Myristate,Phosphoprotein,Reference proteome,Synapse,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase ZNRF2,compositionally biased region:Ala-rich,compositionally biased region:Poly-Gly,lipid moiety-binding region:N-myristoyl glycine,modified residue,zinc finger region:RING-type; atypical,
ENSG00000119703	zinc finger C2HC-type containing 1C(ZC2HC1C)	Homo sapiens						GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR026104:Zinc finger C2HC domain-containing protein 1C,						Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Reference proteome,Zinc,Zinc-finger,	chain:UPF0418 protein FAM164C,sequence conflict,
ENSG00000102053	zinc finger CCCH-type containing 12B(ZC3H12B)	Homo sapiens				GO:0090305~nucleic acid phosphodiester bond hydrolysis,		GO:0004519~endonuclease activity,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR021869:Ribonuclease Zc3h12a-like,						Alternative splicing,Complete proteome,Endonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Reference proteome,Zinc,Zinc-finger,	chain:Probable ribonuclease ZC3H12B,zinc finger region:C3H1-type,
ENSG00000162415	zinc finger SWIM-type containing 5(ZSWIM5)	Homo sapiens					GO:0005615~extracellular space,	GO:0008270~zinc ion binding,	IPR007527:Zinc finger, SWIM-type,						Complete proteome,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger SWIM domain-containing protein 5,sequence variant,zinc finger region:SWIM-type,
ENSG00000130449	zinc finger SWIM-type containing 6(ZSWIM6)	Homo sapiens				GO:0048812~neuron projection morphogenesis,GO:2001222~regulation of neuron migration,		GO:0008270~zinc ion binding,	IPR007527:Zinc finger, SWIM-type,		603671~Acromelic frontonasal dysostosis,				Complete proteome,Disease mutation,Dwarfism,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger SWIM domain-containing protein 6,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ser,zinc finger region:SWIM-type,
ENSG00000198393	zinc finger protein 26(ZNF26)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				R-HSA-212436:R-HSA-212436,	SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Signal,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 26,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000056277	zinc finger protein 280C(ZNF280C)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007411~axon guidance,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,IPR025243:Domain of unknown function DUF4195,					SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 280C,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,modified residue,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
ENSG00000177599	zinc finger protein 491(ZNF491)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,					SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 491,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000174306	zinc fingers and homeoboxes 3(ZHX3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0030154~cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,					SM00355:ZnF_C2H2,SM00389:HOX,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Differentiation,DNA-binding,Homeobox,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc fingers and homeoboxes protein 3,DNA-binding region:Homeobox 1,DNA-binding region:Homeobox 2,DNA-binding region:Homeobox 3,DNA-binding region:Homeobox 4,DNA-binding region:Homeobox 5,helix,modified residue,region of interest:Required for homodimerization and interaction with NFYA,region of interest:Required for nuclear localization,region of interest:Required for repressor activity,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,
